Release Date: 15/03/13 17:47 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 626.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%